In vitro analysis of expression vectors for DNA vaccination of horses: The effect of a Kozak sequence

Acta Veterinaria Scandinavica

Volumn 50, Issue 1, 2008, Pages

  Ólafsdóttir, Gudbjörg ^a   Svansson, Vilhjálmur ^a   Ingvarsson, Sigurdur ^a   Marti, Eliane ^b   Torsteinsdóttir, Sigurbjörg ^a  

^a UNIVERSITY OF ICELAND   (Iceland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOMEGALOVIRUS; EQUIDAE;

ALPHA2B INTERFERON; DNA VACCINE; SERUM ALBUMIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; BIOSYNTHESIS; CELL LINE; CYTOMEGALOVIRUS; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; HORSE; IMMUNOLOGY; METHODOLOGY; NUCLEOTIDE SEQUENCE; PLASMID; WESTERN BLOTTING;

ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE; CYTOMEGALOVIRUS; GENETIC VECTORS; HORSES; INTERFERON ALFA-2B; PLASMIDS; SERUM ALBUMIN; TRANSFECTION; VACCINES, DNA;

EID: 57549095591     PISSN: 0044605X     EISSN: None     Source Type: Journal    
DOI: 10.1186/1751-0147-50-44     Document Type: Article

References (32)

1. Is genetic vaccination against allergy possible? R Weiss S Scheiblhofer M Gabler F Ferreira WW Leitner J Thalhamer, International Archives of Allergy and Immunology 2006 139 332 345 10.1159/000091946
2. DNA vaccines for cancer too. M Yu OJ Finn, Cancer Immunology and Immunotherapy 2006 55 119 130 10.1007/s00262-005-0008-7
3. Recent advances in the use of DNA vaccines for the treatment of diseases of farmed animals. S van Drunen Littel-van den Hurk V Gerdts BI Loehr R Pontarollo R Rankin R Uwiera LA Babiuk, Advanced Drug Delivery Reviews 2000 43 13 28 10.1016/S0169-409X(00)00074-0 10967218
4. Immunization of livestock with DNA vaccines: current studies and future prospects. S van Drunen Littel-van den Hurk BI Loehr LA Babiuk, Vaccine 2001 19 2474 2479 10.1016/S0264-410X(00)00476-X 11257380
5. Approaches to enhance the efficacy of DNA vaccines. S Manoj LA Babiuk S van Drunen Littel-van den Hurk, Critical Reviews in Clincal Laboratory Science 2004 41 1 39 10.1080/10408360490269251
6. An improved plasmid DNA expression vector for direct injection into skeletal muscle. J Hartikka M Sawdey F Cornefert-Jensen M Margalith K Barnhart M Nolasco HL Vahlsing J Meek M Marquet P Hobart, Human Gene Therapy 1996 7 1205 1217 10.1089/hum.1996.7.10-1205 8793545
7. Vaccination against equine influenza: quid novi? R Paillot D Hannant JH Kydd JM Daly, Vaccine 2006 24 4047 4061 10.1016/j.vaccine.2006.02.030 16545507
8. Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge. CC Breathnach HJ Clark RC Clark CW Olsen HG Townsend DP Lunn, Vaccine 2006 24 1180 1190 10.1016/j.vaccine.2005.08.091 16194586
9. Equine viral vaccines: the past, present and future. JM Minke JC Audonnet L Fischer, Veterinary Research 2004 35 425 443 10.1051/vetres:2004019 15236675
10. A single immunization with a minute dose of a lentiviral vector-based vaccine is highly effective at eliciting protective humoral immunity against West Nile virus. MC Iglesias MP Frenkiel K Mollier P Souque P Despres P Charneau, Journal of Gene Medicine 2006 8 265 274 10.1002/jgm.837 16308885
11. West Nile virus: Recent trends in diagnosis and vaccine development. G Dauphin S Zientara, Vaccine 2006 25 5563 5576 10.1016/j.vaccine.2006.12.005 17292514
12. Experiences with new generation vaccines against equine viral arteritis, West Nile disease and African horse sickness. NJ MacLachlan UB Balasuriya NL Davis M Collier RE Johnston GL Ferraro AJ Guthrie, Vaccine 2007 25 5577 5582 10.1016/j.vaccine.2006.12.058 17267078
13. Alphavirus replicon particles expressing the two major envelope proteins of equine arteritis virus induce high level protection against challenge with virulent virus in vaccinated horses. UB Balasuriya HW Heidner NL Davis HM Wagner PJ Hullinger JF Hedges JC Williams RE Johnston W David Wilson IK Liu N James MacLachlan, Vaccine 2002 20 1609 1617 10.1016/S0264-410X(01)00485-6 11858869
14. West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays. BS Davis GJ Chang B Cropp JT Roehrig DA Martin CJ Mitchell R Bowen ML Bunning, Journal of Virology 2001 75 4040 4047 11287553 10.1128/JVI.75.9.4040-4047.2001
15. Regional antibody and cellular immune responses to equine influenza virus infection, and particle mediated DNA vaccination. G Soboll DW Horohov BM Aldridge CW Olsen MW McGregor RJ Drape MD Macklin WF Swain DP Lunn, Veterinary Immunology and Immunopathology 2003 94 47 62 10.1016/S0165-2427(03)00060-6
16. Powerful and versatile enhancer-promoter unit for mammalian expression vectors. MK Foecking H Hofstetter, Gene 1986 45 101 105 10.1016/0378-1119(86) 90137-X 3023199
17. Comparison of various expression plasmids for the induction of immune response by DNA immunization. AH Lee YS Suh JH Sung SH Yang YC Sung, Mol Cells 1997 7 4 495 501 9339893
18. Technical issues in construction of nucleic acid vaccines. PF Ertl LL Thomsen, Methods 2003 31 199 206 10.1016/S1046-2023(03)00134-8 14511952
19. Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells. BS Chapman RM Thayer KA Vincent NL Haigwood, Nucleic Acids Research 1991 19 3979 3986 1650459 10.1093/nar/19.14.3979
20. How introns influence and enhance eukaryotic gene expression. H Le Hir A Nott MJ Moore, Trends in Biochemical Sciences 2003 28 215 220 10.1016/S0968-0004(03)00052-5 12713906
21. An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. M Kozak, Nucleic Acids Resarch 1987 15 8125 8148 10.1093/nar/15.20.8125
22. At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells. M Kozak, Journal of Molecular Biology 1987 196 947 950 10.1016/0022-2836(87)90418-9 3681984
23. Human serum albumin model for comarison of expression vectors for DNA vaccination of horses. V Svansson G Olafsdottir FS Eiriksdottir E Jörundsson H Arnadottir E Marti S Torsteinsdottir, Veterinary Immunology and Immunopathology
24. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. M Kozak, Cell 1986 44 283 292 10.1016/0092-8674(86)90762-2 3943125
25. Regulation of translation via mRNA structure in prokaryotes and eukaryotes. M Kozak, Gene 2005 361 13 37 10.1016/j.gene.2005.06.037 16213112
26. The intraleader AUG nucleotide sequence context is important for equine arteritis virus replication. D Archambault A Kheyar AA de Vries PJ Rottier, Virus Genes 2006 33 59 68 10.1007/s11262-005-0030-z 16791420
27. Allergic dermatitis (sweet itch) of Icelandic horses in Sweden: an epidemiological study. H Brostrom A Larsson M Troedsson, Equine Veterinary Journal 1987 19 229 236 3608962
28. The probable cause of "sweet itch" in England. PS Mellor J McCraig, Veterinary Record 1974 95 411 415 4451336
29. Studies on allergic dermatitis ("Queensland itch") of the horse. I. - Description, Distribution, Symptoms an Pathology. RF Riek, Australian Veterinary Journal 1953 29 177 184 10.1111/j.1751-0813.1953.tb13937.x
30. Equine insect bite hypersensitivity: immunoblot analysis of IgE and IgG subclass responses to Culicoides nubeculosus salivary gland extract. W Hellberg AD Wilson P Mellor MG Doherr S Torsteinsdottir A Zurbriggen T Jungi E Marti, Veterinaty Immunology and Immunopathology 2006 113 99 112 10.1016/j.vetimm.2006. 04.009
31. Summer eczema in exported Icelandic horses: influence of environmental and genetic factors. S Bjornsdottir J Sigvaldadottir H Brostrom B Langvad A Sigurdsson, Acta Veterinaria Scandinavica 2006 48 3 16987399 10.1186/1751-0147-1-3
32. DNA vaccines for biodefence. HS Garmory SD Perkins RJ Phillpotts RW Titball, Advances in Drug Delivery Reviews 2005 57 1343 1361 10.1016/j.addr.2005.01.013